Cargando…

Multi-utility of therapeutic drug monitoring in inflammatory bowel diseases

Inflammatory bowel disease (IBD) treatment targets have progressed over time from clinical response to clinical and endoscopic remission. Several data have shown a positive correlation between serum biologic drug concentrations and favorable therapeutic outcomes. Therapeutic drug monitoring (TDM) ha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Martins, Camilla de Almeida, Garcia, Karoline Soares, Queiroz, Natália Sousa Freita
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9366431/ https://www.ncbi.nlm.nih.gov/pubmed/35966848 http://dx.doi.org/10.3389/fmed.2022.864888

Ejemplares similares

Active tuberculosis in inflammatory bowel disease patients: a case–control study
por: Freitas Cardoso de Azevedo, Matheus, et al.
Publicado: (2023)

Therapeutic drug monitoring in inflammatory bowel disease
por: Kopylov, Uri, et al.
Publicado: (2014)

Therapeutic drug monitoring in inflammatory bowel disease treatments
por: Wang, Meng-Yao, et al.
Publicado: (2022)

Updates in therapeutic drug monitoring in inflammatory bowel disease
por: Lodhia, Nilesh, et al.
Publicado: (2022)

Therapeutic drug monitoring in inflammatory bowel disease: The dawn of reactive monitoring
por: Albader, Farah, et al.
Publicado: (2021)

Biosimilar knowledge and viewpoints among Brazilian inflammatory bowel disease patients
por: Garcia, Karoline Soares, et al.
Publicado: (2021)

Therapeutic drug monitoring for biological medications in inflammatory bowel disease
por: Cogan, Rachel C., et al.
Publicado: (2022)

Predictive factors of response to infliximab therapy in Brazilian inflammatory bowel disease patients
por: Martins, Camilla de Almeida, et al.
Publicado: (2023)

Coexistence of Takayasu's Arteritis in Patients with Inflammatory Bowel Diseases
por: de Almeida Martins, Camilla, et al.
Publicado: (2021)

Diagnostic Utility of Non-invasive Tests for Inflammatory Bowel Disease: An Umbrella Review
por: Shi, Jin-Tong, et al.
Publicado: (2022)

Therapeutic Drug Monitoring for Current and Investigational Inflammatory Bowel Disease Treatments
por: Lee, Scott D., et al.
Publicado: (2021)

Analytical Pitfalls of Therapeutic Drug Monitoring of Thiopurines in Patients With Inflammatory Bowel Disease
por: Simsek, Melek, et al.
Publicado: (2017)

Advances in Therapeutic Drug Monitoring in Biologic Therapies for Pediatric Inflammatory Bowel Disease
por: Kapoor, Akshay, et al.
Publicado: (2021)

Therapeutic drug monitoring in inflammatory bowel disease: At the right time in the right place
por: Truta, Brindusa
Publicado: (2022)

Innate Lymphoid Cells as Regulators of Epithelial Integrity: Therapeutic Implications for Inflammatory Bowel Diseases
por: Schulz-Kuhnt, Anja, et al.
Publicado: (2021)

Therapeutic drug monitoring of vedolizumab in inflammatory bowel disease: current data and future directions
por: Ward, Mark G., et al.
Publicado: (2018)

Update on TDM (Therapeutic Drug Monitoring) with Ustekinumab, Vedolizumab and Tofacitinib in Inflammatory Bowel Disease
por: Restellini, Sophie, et al.
Publicado: (2021)

A Practical Guide to Therapeutic Drug Monitoring of Biologic Medications for Inflammatory Bowel Disease
por: Vaughn, Byron P.
Publicado: (2021)

Therapeutic Drug Monitoring and Outcome of Infliximab Therapy in Pediatric Onset Inflammatory Bowel Disease
por: Kolho, Kaija-Leena
Publicado: (2021)

Potential Role of Methotrexate Polyglutamates in Therapeutic Drug Monitoring for Pediatric Inflammatory Bowel Disease
por: Morrow, Ryan, et al.
Publicado: (2021)

Therapeutic Drug Monitoring of Biologics for Patients with Inflammatory Bowel Diseases: How, When, and for Whom?
por: Wu, Jia-Feng
Publicado: (2022)

Prognostication in inflammatory bowel disease
por: Spencer, Elizabeth A., et al.
Publicado: (2022)

Inflammatory Bowel Disease (IBD)—A Textbook Case for Multi-Centric Banking of Human Biological Materials
por: Cleynen, Isabelle, et al.
Publicado: (2019)

Is the Therapeutic Drug Monitoring of Anti-TNF Agents Necessary in Korean Inflammatory Bowel Disease Patients?
por: Eun, Chang Soo
Publicado: (2017)

Personalized Medicine of Monoclonal Antibodies in Inflammatory Bowel Disease: Pharmacogenetics, Therapeutic Drug Monitoring, and Beyond
por: Di Paolo, Antonello, et al.
Publicado: (2021)

A Review of Therapeutic Drug Monitoring in Patients with Inflammatory Bowel Disease Receiving Combination Therapy
por: Patel, Sanket, et al.
Publicado: (2023)

JAK inhibitors: A new dawn for oral therapies in inflammatory bowel diseases
por: Herrera-deGuise, Claudia, et al.
Publicado: (2023)

Intestinal Epithelium in Inflammatory Bowel Disease
por: Coskun, Mehmet
Publicado: (2014)

Serum Biomarkers for Inflammatory Bowel Disease
por: Chen, Peng, et al.
Publicado: (2020)

Drug persistence and need for dose intensification to adalimumab therapy; the importance of therapeutic drug monitoring in inflammatory bowel diseases
por: Gonczi, Lorant, et al.
Publicado: (2017)

Are Probiotics or Prebiotics Useful in Pediatric Irritable Bowel Syndrome or Inflammatory Bowel Disease?
por: Guandalini, Stefano
Publicado: (2014)

Therapeutic Drug Monitoring of Biologics in IBD: Essentials for the Surgical Patient
por: Nones, Rodrigo Bremer, et al.
Publicado: (2021)

New Strategies for Treatment of Inflammatory Bowel Disease
por: Nielsen, Ole Haagen
Publicado: (2014)

Predicting Response to Vedolizumab in Inflammatory Bowel Disease
por: Meserve, Joseph, et al.
Publicado: (2020)

Co-pathogens in Periodontitis and Inflammatory Bowel Disease
por: Cai, Zhengwen, et al.
Publicado: (2021)

Editorial: Game Changers in Inflammatory Bowel Diseases
por: Bálint, Anita, et al.
Publicado: (2021)

Real-world use of ustekinumab therapeutic drug monitoring in moderate to severe psoriasis
por: Elberdín, Laida, et al.
Publicado: (2022)

Stress and Inflammatory Bowel Disease: Clear Mind, Happy Colon
por: De Sousa, Joaquim Francisco Maria, et al.
Publicado: (2022)

Therapeutic Drug Monitoring of Vedolizumab in Inflammatory Bowel Disease Patients during Maintenance Treatment—TUMMY Study
por: Sivridaş, Merve, et al.
Publicado: (2023)

Efficacy of Early Optimization of Infliximab Guided by Therapeutic Drug Monitoring during Induction—A Prospective Trial
por: Garcia, Karoline Soares, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_03sclu9qic4gqvtq9kc3815g88